DRAPER, Utah, Jan 31, 2006 (BUSINESS WIRE) -- One World Nutrition Inc. (Pink Sheets: OWDN), makers of the TriGeniX Nutritional Systems, announced the closing of its initial private placement offering. The private placement, commenced in August 2004 and sold to accredited investors only, raised $3 million at $1.50 per share of common stock sold.
About One World Nutrition Inc. and TriGeniX
One World Nutrition Inc. is a Nevada corporation engaged in the business of selling proprietary nutritional supplements under the brand name TriGeniX. The company spent the past three years perfecting the products and packaging in order to begin mass marketing through a professionally produced infomercial and radio advertisements.
The TriGeniX System provides the vitamins, nutrients, amino acids and enzymes necessary for the constant rejuvenating process. The complete TriGeniX System provides:
(1) a Liquid Nutritional Dietary Supplement packed with natural vitamins and nutrients and a proprietary blend of adaptogens,
(2) a Vitamin Pack that provides the essential vitamins and minerals that a person can't get from even the best diet, with each packet containing a multivitamin and mineral capsules, a vitamin C complex, plus a joint and vision formula; and
(3) a Fruit and Vegetable Pack with 25 fruits and 21 vegetables provides the phytonutrients and digestive enzymes that assist in maintaining a healthy body.
The TriGeniX essential system is a complete nutritional system for the health-conscious individual. The TriGeniX sports system meets the nutritional needs of very active, competitive athletes.
Legal Notice Regarding Forward-Looking Statements
This release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934 that are based upon current expectations or beliefs, as well as a number of assumptions about future events. Although the company believes that the expectations reflected in the forward-looking statements and the assumptions upon which they are based are reasonable, it can give no assurance that such expectations and assumptions will prove to have been correct. The reader is cautioned not to put undue reliance on these forward-looking statements, as these statements are subject to numerous factors and uncertainties, including but not limited to economic conditions generally, intense competition, lack of research results, entry of new competitors and products into the company's marketplace, potential federal, state and local government regulation, inadequate capital resources, unexpected costs, operating deficits, increases in general and administrative costs, termination of contracts or agreements, price increases for supplies and components, unanticipated losses, the possible fluctuation and volatility of the company's operating results, dilution in the company's ownership of its business, adverse publicity and news coverage, inability to carry out research, development and commercialization plans, loss or retirement of key executives and research scientists, changes in interest rates, inflationary factors, and other specific risks.